Literature DB >> 2921151

Results of postoperative irradiation of medulloblastoma in adults.

J Skołyszewski1, B Gliński.   

Abstract

This study analyzes the results of combined surgery and radiation therapy in 13 cases of medulloblastoma in adults treated at the Institute of Oncology in Cracow between 1974-1980. There were 5 women and 8 men. The mean age of the patients was 22.4 years. The overall crude 5-year survival was 62%. Four patients developed recurrence at the primary site (in one case local recurrence was concurrent with pulmonary metastases). The posterior fossa dose in these patients was 2625, 3000, 4800, and 5000 cGy. All 5-year survivors received the posterior fossa dose ranging from 5000 to 5400 cGy. For optimal local control the posterior fossa dose of at least 5400 cGy is recommended, with prior irradiation of the whole cranio-spinal axis.

Entities:  

Mesh:

Year:  1989        PMID: 2921151     DOI: 10.1016/0360-3016(89)90346-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature.

Authors:  M Balducci; S Chiesa; D Chieffo; S Manfrida; N Dinapoli; A Fiorentino; F Miccichè; V Frascino; C Anile; V Valentini; B De Bari
Journal:  J Neurooncol       Date:  2011-07-31       Impact factor: 4.130

Review 2.  High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature.

Authors:  P H Cottu; S Giacchetti; L Mignot; B Epardeau; B Visot; J M Extra; M Espie; M Marty
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Cerebellar Medulloblastoma in Middle-to-Late Adulthood.

Authors:  Majid Aljoghaiman; Mahmoud S Taha; Marwah M Abdulkader
Journal:  Case Rep Pathol       Date:  2018-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.